
What factors drive the 7MM Angelman syndrome market?
The rare neurogenetic disorder affects around 500,000 people worldwide. Rising prevalence, greater awareness and diagnosis, and the introduction of new therapies are expected to drive growth in the Angelman syndrome market across the seven major markets ( …